| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 35452* | 2014 |
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2355 | 2011 |
| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 2188 | 2020 |
| Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis M Panigada, N Bottino, P Tagliabue, G Grasselli, C Novembrino, ... Journal of thrombosis and haemostasis 18 (7), 1738-1742, 2020 | 1679 | 2020 |
| Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Heart Attack Risk in Puget Sound. Schwartz Stephen M 20 26 Siscovick David S ... Nature genetics 41 (3), 334-341, 2009 | 1364 | 2009 |
| Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. M Scully, BJ Hunt, S Benjamin, R Liesner, P Rose, F Peyvandi, B Cheung, ... British journal of haematology 158 (3), 2012 | 1157 | 2012 |
| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 1077 | 2019 |
| Caplacizumab for acquired thrombotic thrombocytopenic purpura F Peyvandi, M Scully, JA Kremer Hovinga, S Cataland, P Knöbl, H Wu, ... New England Journal of Medicine 374 (6), 511-522, 2016 | 779 | 2016 |
| The past and future of haemophilia: diagnosis, treatments, and its complications F Peyvandi, I Garagiola, G Young The Lancet 388 (10040), 187-197, 2016 | 686 | 2016 |
| Recessively inherited coagulation disorders PM Mannucci, S Duga, F Peyvandi Blood 104 (5), 1243-1252, 2004 | 653 | 2004 |
| A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 614 | 2016 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 609 | 2021 |
| New susceptibility locus for coronary artery disease on chromosome 3q22. 3 J Erdmann, A Großhennig, PS Braund, IR König, C Hengstenberg, ... Nature genetics 41 (3), 280-282, 2009 | 590 | 2009 |
| Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders F Peyvandi, R Palla, M Menegatti, SM Siboni, S Halimeh, B Faeser, ... Journal of Thrombosis and Haemostasis 10 (4), 615-621, 2012 | 564 | 2012 |
| Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies M Scully, S Cataland, P Coppo, J De La Rubia, KD Friedman, JK Hovinga, ... Journal of thrombosis and haemostasis 15 (2), 312-322, 2017 | 530 | 2017 |
| ISTH guidelines for treatment of thrombotic thrombocytopenic purpura XL Zheng, SK Vesely, SR Cataland, P Coppo, B Geldziler, A Iorio, ... Journal of Thrombosis and Haemostasis 18 (10), 2496-2502, 2020 | 449 | 2020 |
| Rare bleeding disorders: diagnosis and treatment R Palla, F Peyvandi, AD Shapiro Blood, The Journal of the American Society of Hematology 125 (13), 2052-2061, 2015 | 399 | 2015 |
| ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura XL Zheng, SK Vesely, SR Cataland, P Coppo, B Geldziler, A Iorio, ... Journal of Thrombosis and Haemostasis 18 (10), 2486-2495, 2020 | 389 | 2020 |
| Role of von Willebrand factor in the haemostasis F Peyvandi, I Garagiola, L Baronciani Blood Transfusion 9 (Suppl 2), s3, 2011 | 386 | 2011 |
| ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases M Rieger, PM Mannucci, JAK Hovinga, A Herzog, G Gerstenbauer, ... Blood 106 (4), 1262-1267, 2005 | 382 | 2005 |
